| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider activity in AGMB over the last quarter tilts toward buying: insiders added a net 36,000 shares worth roughly $311K. In the past 30 days, 3 insiders bought and 0 sold. The tilt toward buying has held up recently.
The largest recent buyer is Knotnerus Tim Jasper (Chief Executive Officer), now holding an estimated $190K in AGMB. Purchases at the executive level are worth more attention than sales, since sales can be prompted by tax or liquidity needs rather than a view on the stock.
Classified under Biotechnology (Healthcare sector), AGMB's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 57.5K | - | - | |
| Dir | 56.3K | - | - | |
| CEO | 21.8K | $189.9K | +11.0K | |
| Dir | 15.0K | $133.5K | +15.0K | |
| CFO | 3.0K | $26.0K | +10.0K |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Oct 8, 2026 | Epstein David R55 | Director | Buy | 5,000 | $8.90 | $44,500.00 | +50.0% | |
| Oct 6, 2026 | Kemula Pierre Thadee Victor | Chief Financial Officer | Buy | 10,000 | $8.59 | $85,940.00 | New | |
| Oct 6, 2026 | Knotnerus Tim Jasper | Chief Executive Officer | Buy | 11,000 | $8.58 | $94,380.00 | +101.6% | |
| Oct 6, 2026 | Epstein David R55 | Director | Buy | 10,000 | $8.64 | $86,350.00 | New |